Evidence map›Paper›PMID 26379832›Full record

ArticleInternational journal of clinical and experimental medicine2015

Resveratrol attenuates inflammation and oxidative stress induced by myocardial ischemia-reperfusion injury: role of Nrf2/ARE pathway.

Liang Cheng, Zhenxiao Jin, Rong Zhao, Kai Ren, Chao Deng, Shiqiang Yu

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in International journal of clinical and experimental medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03115034 (The Protective Effect of Melatonin in Patients Under Carotid Endarterectomy), which is not on this map. Cited by 88 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
88citing papers in PubMed, 2 pooled it
8.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03115034 phase4completednot on this mapstarted 2016, after this paper: background citation

The Protective Effect of Melatonin in Patients Under Carotid Endarterectomy

TypeinterventionalSponsorPeking Union Medical College HospitalRan2016 to 2017Enrolled60ConditionsCarotid StenosisArmsMelatonin, placebo, blank
3 · Its place in the literature

Who cites it

88 citing papers in PubMed, 2 syntheses or guidelines pooled it, 175 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Pharmaceuticals (Basel, Switzerland) · 2024
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

28 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Liang ChengDepartment of Cardiovascular Surgery, Xijing Hospital, The Fourth Military Medical University Xi'an, China.
Zhenxiao JinDepartment of Cardiovascular Surgery, Xijing Hospital, The Fourth Military Medical University Xi'an, China.
Rong ZhaoDepartment of Cardiovascular Surgery, Xijing Hospital, The Fourth Military Medical University Xi'an, China.
Kai RenDepartment of Cardiovascular Surgery, Xijing Hospital, The Fourth Military Medical University Xi'an, China.
Chao DengDepartment of Cardiovascular Surgery, Xijing Hospital, The Fourth Military Medical University Xi'an, China.
Shiqiang YuDepartment of Cardiovascular Surgery, Xijing Hospital, The Fourth Military Medical University Xi'an, China.
Air Force Medical University · CNXijing Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The protective role of resveratrol in myocardial ischemia/reperfusion is not well understood. The aim of this study was to investigate whether resveratrol modulates inflammation and oxidative stress and the possible role of nuclear factor erythroid 2-related factor 2 (Nrf2)/antioxidant response element (ARE) pathway in an ischemia/reperfusion injured rat heart model. Rats were randomly exposed to sham operation, myocardial ischemia/reperfusion (MI/R) alone, and MI/R + resveratrol. The results demonstrated that compared to MI/R, resveratrol improved cardiac function, reduced myocardial infarction area, myocardial myeloperoxidase (MPO) levels, serum creatinine kinase (CK) and lactate dehydrogenase (LDH) levels. Resveratrol also markedly enhanced the activities of antioxidant enzymes superoxide dismutase (SOD) and glutathione peroxidase (GSH-PX), and reduced the level of malondialdehyde (MDA) in MI/R rats. Resveratrol also enhanced levels of Nrf2 and heme oxygenase-1. In summary, these results demonstrated that resveratrol exerted significant antioxidant and cardioprotective effects following myocardial ischemia, possibly through the activation of the Nrf2/ARE signaling pathway.

Indexed as

HO-1MDAmyocardial ischemia/reperfusion injuryNrf-2ResveratrolSOD

Identifiers

PMID26379832
PMCPMC4565215
OpenAlexW2400528393

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.